0930-AA25 201610 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0930 Substance Abuse and Mental Health Services Administration SAMHSA 0900 Department of Health and Human Services HHS Medication Assisted Treatment for Opioid Use Disorders--Nurse Practitioners and Physician Assistants

On July 8, 2016, SAMHSA finalized a rule to increase access to buprenorphine and the combination buprenorphine/naloxone (Medication Assisted Treatment for Opioid Use Disorders) allowing physicians prescribing buprenorphine to treat up to 275 patients. This Notice of Proposed Rulemaking would implement aspects of section 303 of the Comprehensive Addiction Recovery Act by establishing the criteria for Nurse Practitioners and Physicians Assistants to obtain a waiver to treat up to 100 patients.

]]> Other Significant First Time Published in The Unified Agenda Proposed Rule Stage Undetermined Undetermined 42 CFR 8 21 U.S.C. 823(g)(2)(G)(iv) Statutory Final 01/22/2018 Deadline per section 303 of the CARA No NPRM 07/00/2017 Final Action 01/00/2018 Undetermined Undetermined Undetermined No No No 0930-AA22 Related to Brian Altman Legislative Director 0930 Substance Abuse and Mental Health Services Administration SAMHSA 240 276-2009 brian.altman@samhsa.gov 1 Choke Cherry Road, Rockville MD 02857